Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Wang P, Xu YY, Lv TT, Guan SY, Li XM, Li XP, Pan HF.
Angiology. 2019 Feb;70(2):141-159. doi: 10.1177/0003319718787366. Epub 2018 Jul 15.
Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study.
Liu Z, Wang H, Yang Z, Lu Y, Zou C.
Cardiovasc Diabetol. 2023 Sep 2;22(1):236. doi: 10.1186/s12933-023-01974-6.
SGLT2i in Patients with Type 1 Diabetes: Benefits, Risks, and Preventive Strategies.
Ma Y, Zhao Q, Peng H, Nalisa DL, Shan P, Jiang H.
Front Biosci (Landmark Ed). 2023 May 22;28(5):98. doi: 10.31083/j.fbl2805098.
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ.
J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. doi: 10.1210/jc.2019-00198.
Lipid-lowering in diabetes: An update.
Chait A, Eckel RH, Vrablik M, Zambon A.
Atherosclerosis. 2024 Jul;394:117313. doi: 10.1016/j.atherosclerosis.2023.117313. Epub 2023 Oct 6.
Atherosclerosis in Pediatric and Adolescent Type 1 Diabetes-A Case for Early Identification?
Bajpai A.
Indian J Pediatr. 2023 Mar;90(3):215-216. doi: 10.1007/s12098-022-04430-7. Epub 2022 Dec 31.
Atherosclerosis: risk assessment and the role of aiming for optimal glycaemic control in young patients with type 1 diabetes.
Kolasa M, Olejnik A, Rusak E, Chobot A.
Pediatr Endocrinol Diabetes Metab. 2023;29(1):42-47. doi: 10.5114/pedm.2022.122546.
Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.
Kothari V, Ho TWW, Cabodevilla AG, He Y, Kramer F, Shimizu-Albergine M, Kanter JE, Snell-Bergeon J, Fisher EA, Shao B, Heinecke JW, Wobbrock JO, Lee WL, Goldberg IJ, Vaisar T, Bornfeldt KE.
Circ Res. 2024 Jul 5;135(2):335-349. doi: 10.1161/CIRCRESAHA.123.323100. Epub 2024 Jun 3.
[Atherosclerosis in patients with type 1 diabetes].
Karásek D.
Vnitr Lek. 2020 Winter;65(12):775-782.
The impact of vildagliptin as an add-on therapy on matrix metalloproteinase-14 levels, liver stiffness and subclinical atherosclerosis in adolescents with type 1 diabetes and non-alcoholic steatohepatitis: A randomized controlled trial.
ElKabbany ZA, Ismail EAR, Hamed ET, Elbarbary NS.
Diabetes Obes Metab. 2024 Dec;26(12):5857-5869. doi: 10.1111/dom.15958. Epub 2024 Sep 24.
